Back to Search
Start Over
Antiplatelet effect of 600- and 300-mg loading doses of clopidogrel in patients undergoing primary percutaneous coronary intervention for ST-segment elevation myocardial infarction: an analysis of the ARMYDA-6 MI (Antiplatelet therapy for Reduction of MYocardial Damage during Angioplasty-Myocardial Infarction) Study
- Publication Year :
- 2012
-
Abstract
- undergoing primary percutaneous coronary intervention for ST-segment elevation myocardial infarction: an analysis of the ARMYDA-6 MI (Antiplatelet therapy for Reduction of MYocardial Damage during Angioplasty-Myocardial Infarction) Study Fabio Mangiacapra ⁎, Giuseppe Patti , Emanuele Barbato , Dejan Orlic , Aaron J. Peace , Andrea D'Ambrosio , Miodrag Ostojic , William Wijns , Germano Di Sciascio a,⁎,1 a Department of Cardiovascular Sciences, Campus Bio-Medico University, Rome, Italy b Cardiovascular Center Aalst, OLV Hospital, Aalst, Belgium c Department of Diagnostics and Catheterization Laboratories, Division of Cardiology, Clinical Center of Serbia, Medical School of Belgrade, Belgrade, Serbia
- Subjects :
- medicine.medical_specialty
Internationality
Ticlopidine
medicine.medical_treatment
Myocardial Infarction
Infarction
Percutaneous Coronary Intervention
Postoperative Complications
Internal medicine
Angioplasty
medicine
Humans
ST segment
In patient
Prospective Studies
Myocardial infarction
Angioplasty, Balloon, Coronary
Dose-Response Relationship, Drug
business.industry
Medical school
Percutaneous coronary intervention
medicine.disease
Clopidogrel
humanities
Treatment Outcome
Cardiology
Cardiology and Cardiovascular Medicine
business
Platelet Aggregation Inhibitors
medicine.drug
Subjects
Details
- Language :
- English
- Database :
- OpenAIRE
- Accession number :
- edsair.doi.dedup.....4443046dfad2200ae128114cc4a47cb9